The health burden of osteoporosis in men is expected to increase with an aging population and increasing life expectancy. Both hip and vertebral fractures are associated with increased morbidity and mortality in men. The clinical evaluation, measurement of bone mineral density using dual-energy X-ray absorptiometry, laboratory tests and fracture risk assessment is now recognized as the standard for diagnosis of osteoporosis in males, and a preferred approach to guide treatment decisions. Clinical trials have demonstrated efficacy of several treatment options available for men with osteoporosis. Moreover, clinical interventions to improve physical performance could also reduce the risk of future fractures.
Keywords: bone densitometry; epidemiology; osteoporosis; prevention; risk of fracture therapy..